Table 7

Adverse Events with Incidence ≧ 2%

Preferred Term

N = 426

N (%)


Patients with any Adverse Event

213 (50.0%)

Disease progression

33 (7.7%)*

Upper respiratory tract infection

30 (7.0%)

Extrapyramidal disorder

22 (5.2%)

Insomnia

17 (4.0%)

Constipation

14 (3.3%)

Anxiety

11 (2.6%)

Nasopharyngitis

11 (2.6%)

Diarrhoea

9 (2.1%)

Headache

9 (2.1%)

Somnolence

9 (2.1%)

Tachycardia

9 (2.1%)


*27 events were recorded as serious adverse events.

Huang et al. BMC Clinical Pharmacology 2012 12:1   doi:10.1186/1472-6904-12-1

Open Data